cysteamine has been researched along with Parkinson Disease, Secondary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, EH; Cho, SW; Choi, SY; Eum, WS; Hwang, JH; Jeong, HJ; Kang, HW; Kang, TC; Kim, DS; Kim, DW; Kim, MJ; Kwon, OS; Lee, YP; Park, J; Shin, MJ; Sohn, EJ | 1 |
1 other study(ies) available for cysteamine and Parkinson Disease, Secondary
Article | Year |
---|---|
PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Death; Cell Line, Tumor; Cysteamine; DNA Fragmentation; Dopaminergic Neurons; Escherichia coli; HSP27 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Parkinson Disease, Secondary; Peptides; Reactive Oxygen Species; Recombinant Fusion Proteins; Rotarod Performance Test; Substantia Nigra | 2012 |